You are here:

Category: 11.8 Miscellaneous ophthalmic preparations

Name SMC ID No Manufacturer Status Sub. Type
 
aflibercept (Eylea) 857/13 Bayer plc/Bayer Schering Pharma Accepted Full submission
aflibercept (Eylea) 1003/14 Bayer plc/Bayer Schering Pharma Restricted Full submission
aflibercept (Eylea) 1074/15 Bayer plc/Bayer Schering Pharma Accepted Full submission
aflibercept intravitreal (Eylea®) 954/14 Bayer plc/Bayer Schering Pharma Accepted Full submission
bromfenac (Yellox) 740/11 Bausch and Lomb GmbH Not Recommended Non submission
Carbomer 0.25% gel (Liquivisc®) 191/05 Allergan Ltd Accepted Abbreviated Submission
idebenone (Raxone) 1226/17 Santhera Pharmaceuticals Restricted Full submission
nepafenac (Nevanac) 588/09 Alcon Laboratories UK Ltd Not Recommended Non submission
nepafenac (Nevanac) 813/12 Alcon Laboratories UK Ltd Accepted Full submission
nepafenac (Nevenac) 1228/17 Alcon Laboratories UK Ltd Accepted Abbreviated Submission
ocriplasmin (Jetrea) 892/13 Thrombogenics NV Restricted Resubmission
Pegaptanib (Macugen) 290/06 Pfizer Ltd Superseded Full submission
ranibizumab (Lucentis) 711/11 Novartis Pharmaceuticals UK Ltd Not Recommended Full submission
ranibizumab (Lucentis) 711/11 Novartis Pharmaceuticals UK Ltd Restricted Resubmission
ranibizumab (Lucentis) 732/11 Novartis Pharmaceuticals UK Ltd Restricted Full submission
ranibizumab (Lucentis) 732/11 Novartis Pharmaceuticals UK Ltd Accepted Resubmission
ranibizumab (Lucentis) 907/13 Novartis Pharmaceuticals UK Ltd Accepted Full submission
ranibizumab 10mg/ml solution for intravitreal injection (Lucentis) 381/07 Novartis Pharmaceuticals UK Ltd Superseded Full submission

Back